Vital KSK Holdings, Inc. (TYO:3151)

Vital KSK Holdings Revenue

Vital KSK Holdings had revenue of 155.21B JPY in the quarter ending September 30, 2026, with 2.07% growth. This brings the company's total for the last twelve months to 620.07B, up 2.74% year-over-year. In the fiscal year ending March 31, 2026, Vital KSK Holdings had annual revenue of 610.50B with 1.69% growth. That makes Vital KSK Holdings the 3,168th largest company in the world by revenue and 313th in Japan.

• Revenue (ttm): 620.07B
• Revenue Growth: +2.74%
• P/S Ratio: 0.11
• Revenue / Employee: 160.18M
• Employees: 3,871
• Market Cap: 67.78B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Wholesale Business 583.85B 93.5%
• Pharmacy Business 19.97B 3.2%
• Veterinary Drug Wholesale Business 12.63B 2.0%
• Nursing Care-related Rental and Other Business 7.87B 1.3%

Fiscal year ended Mar 31, 2026 See the full Vital KSK Holdings breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	610.50B	10.13B	1.69%
Mar 31, 2025	600.37B	12.89B	2.19%
Mar 31, 2024	587.48B	7.71B	1.33%
Mar 31, 2023	579.77B	2.52B	0.44%
Mar 31, 2022	577.25B	40.22B	7.49%

Data Source: S&P Global Market Intelligence Last updated: Nov 9, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error